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Abstract
c-Aminobutyric acid type A receptors (GABAA receptors) are chloride ion channels composed of five subunits, mediating
fast synaptic and tonic inhibition in the mammalian brain. These receptors show near five-fold symmetry that is most
pronounced in the second trans-membrane domain M2 lining the Cl2 ion channel. To take advantage of this inherent
symmetry, we screened a variety of aromatic anions with matched symmetry and found an inhibitor, pentacyanocyclo-
pentdienyl anion (PCCP2) that exhibited all characteristics of an open channel blocker. Inhibition was strongly dependent
on the membrane potential. Through mutagenesis and covalent modification, we identified the region a1V256-a1T261 in
the rat recombinant GABAA receptor to be important for PCCP
2 action. Introduction of positive charges into M2 increased
the affinity for PCCP2 while PCCP2 prevented the access of a positively charged molecule into M2. Interestingly, other anion
selective cys-loop receptors were also inhibited by PCCP2, among them the Drosophila RDL GABAA receptor carrying an
insecticide resistance mutation, suggesting that PCCP2 could serve as an insecticide.
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Introduction
Symmetry pervades nature at all levels from nuclear physics to
astronomy [1]. In biology, it enables complex functions to arise
from a limited set of building blocks and associated genes. A case
in point is protein assemblies, such as viral capsids or trans-
membrane ion channels. The former often show icosahedral
symmetry, allowing for the encapsulation of maximum space with
a minimum number of protein components [2]. The latter are
often multimeric, for instance tetrameric (voltage-gated potassium
channels), pentameric (cys-loop receptors) or hexameric (Orai
channels), with a central pore formed by membrane-spanning
subunits. Following the establishment of a basic multimeric
assembly early in evolution, a higher level of functional
sophistication is sometimes achieved through subsequent desym-
metrization, for instance through concatenation or heteromulti-
merization of closely related, yet distinct, subunits.
GABAA receptors are a particularly interesting class of
pentameric ligand-gated ion channels. They are composed of five
subunits surrounding a central chloride ion channel and represent
the major inhibitory receptors in the mammalian central nervous
system [3–6]. The most abundant receptor isoform in mammalian
brain consists of a1, b2, and c2 subunits [7]. Various approaches
have been used to derive the subunit stoichiometry for this
receptor, which has been determined as 2a:2b:1c. with a subunit
arrangement gbaba anti-clockwise as seen from the synaptic cleft
[8–12]. The pharmacological properties depend on subunit
composition [13] and arrangement [14]. The subunits of GABAA
receptors share a high degree of homology with other subunits of
the same receptors, as well as subunits of other Cys-loop receptors.
All these receptors have a near five-fold symmetry. The degree of
symmetry is especially high in the second trans-membrane domain
M2 that lines the ion channel (Fig 1A).
GABAA receptors have a rich pharmacology and are targeted
by numerous agents such as muscimol, picrotoxin, benzodiaze-
pines and insecticides [15]. None of these ligands, however, takes
advantage of the five-fold (or near five-fold) symmetry of the
receptors and the availability of multiple, i.e. up to five, related
contact sites. Encouraged by recent work on polyvalent ligands
[16], we hypothesized that small pentasymmetric or nearly
pentasymmetric anions would serve as symmetry-adapted blockers
of the anion-selective GABAA receptors. Such molecules would
have multiple similar interactions with the protein, which would
result in a sharp increase of overall binding affinity (avidity) due to
the polyvalency effect [17]. To test this hypothesis, we synthesized
a range of perfectly or nearly five-fold symmetric anions
(Figure 2A) and investigated them in electrophysiological exper-
iments. Among these, we identified the pentacyanocyclopentdienyl
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anion (PCCP2) as an inhibitor of GABAA receptors. Here we
describe that PCCP2 has all the hallmarks of an open channel
blocker, discuss its binding site, and evaluate its interactions with
other pentameric ligand-gated on channels.
Materials and Methods
Compounds 1 (Na+PCCP2) and 2 were synthesized using
established literature protocols. Compounds 3 and 4 were
synthesized from 2 by treatment with ammonia and hydrazine,
respectively. Details of these syntheses will be published elsewhere.
Crystallographic data (excluding structure factors) for
Na+PCCP2 (acetone solvate) have been deposited with the
Cambridge Crystallographic Data Centre as publication
no. CCDC-946841. Copies of the data can be obtained free of
charge on application to CCDC, 12 Union Road, Cambridge.
MTSET+ was obtained from Toronto Research Chemicals Inc.
All the other chemicals were purchased from Sigma-Aldrich.
The recombinant rat mutant subunits a1A253C, a1V256C,
a1T260C, a1T261C, a1L263C, a1T264C, a1T267C putatively
facing the channel lumen (Fig. 1A,B) were prepared using the
QuikChange mutagenesis kit (Stratagene).
Capped cRNAs were synthesized from the linearized plasmids.
A poly-A tail of about 400 residues was added to each transcript
using yeast poly-A polymerase. The concentration of the cRNA
was quantified on a formaldehyde gel using Radiant Red stain for
visualization of the RNA. Known concentrations of RNA ladder
were loaded as standard on the same gel. cRNAs were precipitated
in ethanol/isoamylalcohol 19:1, the dried pellet dissolved in water
and stored at 280uC. Xenopus oocytes were prepared, injected
and defollicated as described previously [18] (Research approved
by the Kantonstierarzt, Kantonaler Veterina¨rdienst Bern (Animal
research permit BE98/12)). Briefly, Xenopus laevis oocytes were
injected with 50 nL of the cRNA solution containing wild type or
mutated a1, b2 and c2 subunits at a concentration of 10 nM:
10 nM: 50 nM and then incubated in modified Barth’s solution at
18uC for at least 24 h before the measurements. Homomeric
glycine receptors (b-subunit), heteromeric glycine receptors (a and
b-subunit) (cDNAs are a kind gift by B. Laube and H. Betz), the
prokaryotic ELIC (cDNA is a kind gift by R. Dutzler), the wild-
type and the dieldrin resistant (RDL) mutant Drosophila GABAA
receptor (wild type, bd splice variant and mutant A301S) (cDNAs
are a kind gift by D. Sattelle) were also expressed. Currents were
measured using a home-built two-electrode voltage clamp
amplifier in combination with a XY-recorder or digitized using
a PowerLab 2/20 (AD Instruments) using the computer program
Chart. Tests with a model oocyte were performed to ensure
linearity in the larger current range. The response was linear up to
15 mA. Electrophysiological experiments were performed by using
the two-electrode voltage clamp method at a holding potential of
280 mV. The perfusion medium contained 90 mM NaCl, 1 mM
KCl, 1 mM MgCl2, 1 mM CaCl2, and 5 mM Na-HEPES
(pH 7.4) and was applied by a gravity flow of 6 ml/min. Wild
type and and mutant receptors were characterized for their
apparent affinity for c-aminobutyric acid (GABA) for channel
gating and for inhibition by PCCP2 and picrotoxin. The GABA
concentration response curve was determined by sequential
application of increasing concentrations of GABA. Concentra-
tion-inhibition curves were performed at GABA (EC10) by
Figure 1. Aligned sequences of the amino acid residues in the
subunits a1b2c2 of the rat GABAA receptor. A, Alignment of 2a, 2b
and 1c subunit contributing to the formation of a GABAA pentamer. The
residues in the a1 subunit of the GABAA mutated to Cys are shown in
boldface letters. B, a-Helical wheel representation of the rat a1 M2
membrane-spanning domain showing the mutated residues in boldface
letters.
doi:10.1371/journal.pone.0106688.g001
Figure 2. Symmetry-adapted anions, the chemical structure of
PCCP2 and the X-ray structure of Na+PCCP2. A, Symmetry-
adapted anions. B, X-ray structure of Na+PCCP2 (as the acetone solvate).
The network of coordinative interactions between the partially
negatively charged nitrogen atoms of PCCP2 and the Na+ cations is
highlighted. The insert indicates the geometry of the molecule.
doi:10.1371/journal.pone.0106688.g002
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sequential co-application of GABA and increasing concentrations
of PCCP2 or picrotoxin. Inhibition was determined at the end of
1 min co-application of GABA and PCCP2 or picrotoxin.
Concentration response curves were fitted with I(c) = Imax/(1+
(c/EC50)‘n, where I is the current potentiation, c is the
concentration of GABA, Imax is the maximal current amplitude,
EC50 is the concentration of GABA at which a half-maximal
current amplitude was observed and n is the Hill coefficient.
Concentration inhibition curves were fitted with I(c) = Imax/(1+
(IC50/c)), where I is the control current amplitude, c is the
concentration of PCCP2 or picrotoxin, Imax is the control current
amplitude elicited by GABA and IC50 is the concentration of
PCCP2 or picrotoxin at which half-maximal inhibition was
observed. Drugs were applied as follows: 1 min GABA (EC10),
Figure 3. Effect of PCCP2 on recombinant a1b2c2 GABAA receptors. A, GABAA receptors were expressed in Xenopus oocytes. The electrical
currents recorded by two-electrode voltage clamp were activated with a concentration of GABA eliciting 1% of the maximal current amplitude (EC1)
and inhibited with increasing concentrations of PCCP2. The lower bar indicates the time of GABA application, the upper bar the time of PCCP2
application. The numbers indicate the concentration of PCCP2 in mM. At concentrations .1 mM, induces an open-channel block, characterized by an
apparent desensitization of the current and an off-current. B, Averaged concentration inhibition curve by PCCP2. Individual curves were fitted and
standardized to the current elicited by GABA. Data are shown as mean 6 SEM (n = 4). Open circle: peak current amplitudes at the beginning of the
drug application. Filled squares: current amplitudes at the end of the drug application. Filled circles: current amplitudes at the end of the drug
application corrected for the direct effect of PCCP2 on membranes. C) and D) same experiment carried out at a concentration of GABA eliciting 10%
of the maximal current amplitude (EC10).
doi:10.1371/journal.pone.0106688.g003
Figure 4. Concentration inhibition curves for rat and Drosophila GABAA receptors. A, Concentration inhibition curve for a1b2c2 and a1b2d
GABAA receptors. Increasing concentrations of PCCP
2 were applied together with GABA EC10. Individual inhibition curves were standardized and
subsequently averaged (Mean 6 SD, n = 4). Data are compared with those obtained from a1b2c2 receptors. Inhibition of the wild type and mutant
RDL Drosophila GABAA receptor by PCCP
2 and Picrotoxin. Concentration inhibition curves of (B) PCCP2 and, (C) picrotoxin were determined in wild
type (circles) and mutant (squares) receptors. Currents were activated with a concentration of GABA eliciting 10% of the maximal current amplitude
(EC10) and inhibited with increasing concentration of PCCP
2 or picrotoxin. Individual curves were standardized to initial current amplitudes and
subsequently averaged. Data are shown as mean 6 SD (n = 3).
doi:10.1371/journal.pone.0106688.g004
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1 min GABA (EC10), 1 min GABA (EC10) + PCCP2 (IC50), 1 min
MTSET+ (5 mM) either in the presence or absence of 100 mM
GABA, 1 min GABA (EC10), 1 min GABA (EC10), 1 min GABA
(EC10) + PCCP2 (concentration as before). Similar experiments
were performed with picrotoxin. Due to the difficulty of washing
out picrotoxin out from the oocytes two different oocytes were
used to test the inhibition before and after the treatment with the
cysteine reactive compound. Inhibition after treatment was
divided by % inhibition before treatment. To test the ability of
PCCP2 to protect the engineered cysteines from covalent
modification by MTSET+, we used the same sequence of
Figure 5. Effect of the membrane potential on inhibition by
PCCP2. A, GABAA receptors were activated with a concentration of
GABA eliciting 10% of the maximal current amplitude (EC10) and
inhibited with increasing concentrations of PCCP2. Averaged concen-
tration inhibition curves by PCCP2 are shown for different membrane
potentials. Individual curves were fitted and standardized to the current
elicited by GABA. Data are shown as mean 6 SD (n = 3).
doi:10.1371/journal.pone.0106688.g005
Figure 6. High concentration of PCCP2 induce a current in non-
injected Xenopus oocytes. A, Voltage jump of 25 ms duration from
280 mV to 230 mV. A mA sized transient current flows with each
voltage step. B, A small transient outward current is induced after
applications of 10, 30 and 100 mM PCCP2 of 30 s duration to an oocyte
held at a membrane potential of 280 mV.
doi:10.1371/journal.pone.0106688.g006
Figure 7. Pharmacological properties of wild type and cysteine
mutant GABAA receptors. A, GABA concentration response curves
from wild type and mutant rat GABAA receptor. B, PCCP
2 and C,
picrotoxin concentration inhibition curves. Individual curves were fitted
and standardized. Data are shown as mean 6 SD (n = 3 to 4).
doi:10.1371/journal.pone.0106688.g007
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perfusion except that MTSET+ was co-applied with 1 mM
PCCP2. Results were obtained on 3–4 single oocytes for each
receptor.
The homology model is based on PDB entry 3RIF and was
constructed with Modeller [19]. Ligand docking was performed
with the GOLD software [20]. The binding site was defined to
contain the 29and 69 residues, side chains a1T260, b2T256 and
c2T271 were kept flexible during docking.
Results
Synthesis and preliminary biological evaluation
Figure 2A shows the investigated symmetry-adapted anions.
PCCP2 as its sodium salt [1] and compound 2 were synthesized
following established literature procedures [21–23]. Compounds 3
and 4 were prepared from 2 by treatment with ammonia and
hydrazine, respectively. Details of these syntheses will be published
elsewhere. Compounds 1–4 were tested for inhibition of recom-
binant a1b2c2 GABAA receptors. Among these, only 1 was found
to be highly active and was further characterized and the x-ray
structure determined (Figure 2B).
Low concentrations of PCCP2 inhibit currents mediated
by a1b2c2 GABAA receptors
To evaluate PCCP2 as an ion channel blocker, a1b2c2 rat
GABAA receptors were expressed in Xenopus oocytes. At
concentrations of 0.3–10 mM PCCP2 stimulated currents elicited
by low concentrations of GABA (EC1). This stimulation was highly
variable between individual oocytes and was not mediated by the
site for benzodiazepines as 1 mM Ro15-1788 fails to affect the
stimulation. As stimulation was only observed at low concentration
of GABA, we are tempted to assume a different site of action of
PCCP2 for stimulation and inhibition. At higher concentrations
(.1 mM), PCCP2 induced an open-channel block, characterized
by an apparent desensitization of the current and an off-current.
As expected, this block became more prominent with increasing
agonist concentrations. Stimulation became less evident. Original
current traces and averaged data are shown in Figure 3A,B.
Figure 3C,D shows a similar experiment carried out at a higher
GABA concentration (EC10). At this GABA concentration,
PCCP2 only exhibited a channel block. Current amplitudes
measured after 1 min application of GABA and PCCP2 were
fitted with an IC50 of 2.660.8 mM (n = 4). In additional
experiments PCCP2 was pre-applied for 30 s before the combined
application of PCCP2 with GABA. Current traces looked the
same as without pre-application, indicating that PCCP2 did not
interact with closed channels.
PCCP2 also inhibited a1b2c2 and a1b2d rat GABAA receptors,
respectively, with an IC50 of 12.564.8 mM (n = 4) and
0.7160.28 mM (n = 4) (Figure 4A). It should be noted that the
primary sequences of b1 and b2 differ substantially in the inner
leaflet of M3. Glycine homomeric and heteromeric receptors [24]
were similarly inhibited, while ELIC [25] required about 100 mM
PCCP2 for half-maximal inhibition.
Inhibition by PCCP2 was strongly dependent on the membrane
potential (Figure 5). IC50 was 16.261.3 mM (n = 3) at 2120 mV,
6.361.3 mM (n = 3) at 280 mV and 1.860.8 mM (n = 3) at
240 mV. It should be noted that the IC50 at 280 mV was for
unknown reasons somewhat higher than determined in the
experiments before. From these values one can estimate the
fraction of the voltage field experienced by the blocking particle at
its blocking site from the equation derived by Woodhull [26]
where d is the fraction of the voltage field sensed by the blocker
from the outside of the membrane. d was estimated to be ,0.7 the
distance of the voltage field from the extracellular side.
In additional experiments it was tested of inhibition by PCCP2
was of competitive or non-competitive nature. GABA concentra-
tion response curves were carried out in the absence of PCCP2 or
the presence of 2 mM or 10 mM PCCP2. Analysis was complicated
by the fact that currents were determined after 1 min application
of GABA, when a substantial proportion of the channels had been
desensitized. Nevertheless data showed rather a leftward shift of
the GABA concentration response curve with increasing concen-
trations of PCCP2, a phenomenon excluding competitive
inhibition.
High concentrations of PCCP2 interact with the lipid
bilayer
At concentrations $10 mM, PCCP2 induced a current in non-
injected oocytes. Perfusion of 10, 30 or 100 mM PCCP2 at a
holding potential of 280 mV resulted in small outward currents
(Figure 6B). Upon a voltage jump from 280 to 230 mV, mA sized
currents of more than 30 ms duration were observed in the
presence of 100 mM PCCP2 (Fig. 6A). Thus it appears that
PCCP2 is able to insert into the bilayer and diffuse through the
bilayer, reflecting its lack of dipole moment and relative
lipophilicity (clogP =20.48). It should be noted that the
concentrations of PCCP2 required to induce currents in non-
injected oocytes are much larger than the concentrations required
to inhibit GABAA receptor channels.
Table 1. Pharmacological evaluation of the expressed recombinant receptors.
Receptor GABA EC50 (mM) mean ± SD n PCCP
2 IC50 (mM) mean ± SD n Picrotoxin IC50 (mM) mean ± SD n
a1b2c2 31.366.5 3 2.5860.75 3 2.0260.89 6
a1A253Cb2c2 30.666.4 3 2.6360.31 3 1.7960.15 3
a1V256Cb2c2 2.9167.4 4 62.2622.4 4 0.7460.36 4
a1T260Cb2c2 44.166.4 4 0.8560.46 4 1.3160.41 3
a1T261Cb2c2 11161 3 46.467.25 3 1.3160.71 3
a1L263Cb2c2 open ch. 3 4.4761.36 3 1.1060.21 3
a1T264Cb2c2 126624 4 3.1560.48 3 1.0360.35 3
a1T267Cb2c2 32.2611.9 3 0.7760.11 3 0.8360.48 3
EC50 for GABA, IC50 for PCCP
2, and IC50 for picrotoxin are given for wild type and mutant receptors.
doi:10.1371/journal.pone.0106688.t001
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PCCP2 inhibits currents mediated by wild type and
mutant RDL Drosophila GABAA receptor to a similar
extent
Mutation A302S in RDL Drosophila GABAA receptors has
been reported to confer a certain degree of resistance to inhibition
by picrotoxin [27,28]. In our hands, a 7-fold reduction in
sensitivity to picrotoxin upon the mutation was observed.
Interestingly, PCCP2 showed a much smaller (about 2-fold)
difference in the IC50 between wild type and mutant receptors
(Figure 4B.C).
Pharmacological properties of mutant receptors
To identify important residues for the interaction with PCCP2,
we mutated, one at a time, seven residues in M2 of a1 to cysteine
residues. (Figure 1A,B). Mutated a1 subunits were co-expressed
with wild type b2 and c2 subunits in Xenopus oocytes. The
sensitivity to GABA was tested for the different mutants.
Expression of a1L263Cb2c2 resulted in a spontaneously open
channel. While a1A253Cb2c2, a1T260Cb2c2, a1T267Cb2c2
showed an EC50 similar to wild type receptors, the mutant
a1V256Cb2c2 showed an about 10-fold increase and the mutants
a1T261Cb2c2 and a1T264Cb2c2 showed an about 4 fold decrease
in the EC50 for GABA (Figure 7A; Table 1). The sensitivity to
inhibition by PCCP2 of GABA-activated currents was also
determined for wild type and mutant receptors. A GABA
concentration eliciting 10% of the maximal current in the
corresponding receptor was used in these experiments. The
mutant receptors a1V256Cb2c2 and a1T261Cb2c2 displayed each
an about 20–30 fold reduced sensitivity to PCCP2 compared with
wild type receptors (Figure 7B; Table 1). The sensitivity of GABA-
activated currents to picrotoxin was also determined using the
same conditions as for PCCP2 (Fig. 7C; Table 1). Little effect of
the studied mutations was observed on the IC50 for picrotoxin.
The effect of MTSET+ on the cysteine-substitution
mutants and the binding site of PCCP2
A cysteine scan was chosen as it allows covalent reaction with a
cysteine reactive compound to potentially increase the effect seen
with the mutation alone, to test accessibility of the residue and to
investigate protection from the covalent reaction by a compound.
In preliminary experiments pCMBS2, MTSEA+ and MTSET+
were tested. Only treatment with MTSET+ left wild type GABAA
receptors unaffected (Figure 8A). Therefore MTSET+ was chosen
for further experimentation. Current traces for wild type receptor
and a1V256Cb2c2 and a1T260Cb2c2 mutant receptors are shown
in Figure 8B,C and Figure 9A,B, illustrating typical experiments
where we chose an inhibitor concentration such as to inhibit about
50% of the late current response elicited by GABA (EC10) in the
corresponding receptor. MTSET+ + GABA treatment applied for
1 min to the wild type receptor had no effect on the affinity for
PCCP2 (Figure 8A). MTSET+ + GABA treatment in
a1V256Cb2c2 led to an increase in PCCP
2 inhibition (Figure 8B).
This effect could be prevented when 1 mM of PCCP2 was present
during the treatment (Figure 8C). The Figure 9A shows that
MTSET+ + GABA treatment leads to a spontaneously open
channel in the a1T260Cb2c2 mutant, characterized by a shift on
the base line of the current. We applied increasing concentrations
of PCCP2 to investigate if PCCP2 was able to block the channel
again. The IC50 value after the treatment was 0.9060.3 nM
(mean 6 SD, n = 3) as compared to the IC50 of 0.8560.46 mM
(n = 3) before the treatment. This indicates a strongly enhanced
affinity for PCCP2. Moreover, as the maximally inhibited current
level almost reached the original base line we conclude that
PCCP2 was able to close the channel again. Figure 9B documents
that presence of 1 mM PCCP2 during MTSET+ + GABA
treatment prevents the open channel formation and the affinity for
PCCP2 was the same before and after the treatment. Figure 10
summarizes our observations in wild type and mutant receptors.
The bars indicate the ratio of the percentage of inhibition by
PCCP2 (or picrotoxin) observed after application divided by that
before the application of MTSET+ (black bars). The diagrams on
the left show this ratio for PCCP2 (Figure 10A) and picrotoxin
Figure 8. PCCP2 prevents the increase in PCCP2 sensitivity of
a1V256b2c2 mediated by MTSET
+ + GABA. GABA (EC10) was
applied repetitively until a stable current response was observed
followed by inhibition of the channel by PCCP2. Subsequently 5 mM
MTSET was applied in the presence of GABA. After MTSET+ treatment
GABA was applied twice followed by a combined application of GABA
and the same concentration of PCCP2 used before. A, Wild type
receptors were not affected by this treatment. B, The treatment leads to
an enhanced inhibition in a1V256Cb2c2. C, 5 mM MTSET
+ was applied to
a1V256C mutant receptor in presence of GABA and 1 mM PCCP
2.
PCCP2 prevented enhanced inhibition and therefore covalent reaction.
These experiments were repeated independently three times using
different oocytes.
doi:10.1371/journal.pone.0106688.g008
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(Figure 10C) after application of MTSET+ without GABA and the
diagrams on the right show the above ratio for PCCP2
(Figure 10B) and picrotoxin (Figure 10D) after application of
MTSET+ in the presence of GABA. A value of 1 indicates that the
IC50 before and after MTSET
+ treatment were the same. An
increase in the value indicates a decrease in the IC50 of an
inhibitor (increase in apparent affinity) and a decrease below 1 the
opposite. MTSET+ treatment in the absence of GABA caused
generally little change in the apparent affinity of both channel
inhibitors (Figure 10A,C). An exception is the mutant
a1L263Cb2c2 with a significant increase in the ratio for PCCP
2
(p,0.01) and a significant decrease in the ratio for picrotoxin
(p,0.001). This mutation leads to an open channel, to the lumen
of which MTSET+ obviously has access in the absence of GABA.
For those mutations already slightly affected by the MTSET+
treatment alone, the effect on the inhibition by PCCP2 increased
when the MTSET+ treatment was carried out in presence of
100 mM GABA. The application of MTSET+ + GABA caused a
significant increase in the % inhibition by PCCP2 in
a1V256Cb2c2, a1T260Cb2c2, a1T263Cb2c2, a1T264Cb2c2
and a1T267Cb2c2 (each p,0.01) mutants (Figure 9B). Upon
co-application of MTSET+ with GABA, covalent reactions
resulted in the formation of an open channel in a1T260Cb2c2
and a1T264Cb2c2. These open channel currents could not be
further enhanced by GABA. The application of MTSET+ +
GABA also caused a significant decrease in the % inhibition by
picrotoxin in a1V256Cb2c2, a1T260Cb2c2, a1T264Cb2c2 and
a1T267Cb2c2 (each p,0.005) mutants (Figure 10D). To investi-
gate if the covalent reaction after MTSET+ + GABA treatment
could be prevented by the channel inhibitors, we co-applied 1 mM
PCCP2 or picrotoxin during MTSET+ + GABA treatment. In this
case the ratio between the inhibition by PCCP2 or picrotoxin after
treatment, divided by that before the treatment is represented by
the white bars. The increase in PCCP2 sensitivity in the studied
mutant receptors could be prevented in the presence of 1 mM
PCCP2 during MTSET+ + GABA application for all the mutants
affected by the cysteine reactive compound (Figure 10B). The
decrease in picrotoxin sensitivity could not be prevented in the
presence of 1 mM picrotoxin during MTSET+ + GABA
application (Figure 10D).
Discussion
Based on symmetry considerations, we have identified an
aromatic monovalent anion with five-fold symmetry, PCCP2, as
inhibitor of rat GABAA receptors. The exposure to increasing
concentrations of PCCP2 causes inhibition in the GABA-evoked
current typical for an open channel blocker. All the pentameric
receptors belonging to the Cys-loop family share a near five-fold
symmetry which is most pronounced in the second transmem-
brane domain M2. PCCP2 can also inhibit glycine homomeric
and heteromeric receptors with similar affinity to the GABAA
receptor and with smaller affinity ELIC. Interestingly, PCCP2
also inhibits Drosophila wild type and mutant RDL channels
carrying the dieldrin resistance mutation [27,28] suggesting a
possible use of PCCP2 as insecticide. High concentrations of
PCCP2 induced currents by themselves. We ascribe this
phenomenon to distribution of PCCP2 into the lipid bilayer and
Figure 9. PCCP2 prevents the increase in PCCP2 sensitivity of a1T260b2c2 mediated by MTSET
+ + GABA. GABA (EC10) was applied
repetitively until a stable current response was observed followed by inhibition of the channel by PCCP2. Subsequently 5 mM MTSET+ was applied in
the presence of GABA. After MTSET+ treatment GABA was applied twice followed by a combined application of GABA and the same concentration of
PCCP2 used before. A, The treatment leads to a spontaneously open channel and an enhanced inhibition in a1T260Cb2c2. B, 5 mM MTSET
+ was
applied to a1T260C mutant receptor in presence of GABA and 1 mM PCCP
2. PCCP2 prevents the open channel formation. These experiments were
repeated independently three times using different oocytes.
doi:10.1371/journal.pone.0106688.g009
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permeation through the bilayer. PCCP2 lacks a dipole moment
and is therefore comparatively lipophilic with a clogP of 20.48.
However, we can not exclude an action of PCCP2 on channels
endogenous to the oocyte.
We studied the molecular site of interaction of PCCP2 on
a1b2c2 GABAA receptors. A series of cysteine mutations were
introduced in M2 into amino acid residues of the a1 subunit. We
selected residues that have been proposed to line the ion channel
a1A253, a1V256, a1T260, a1T261, a1L263, a1T267 [29,30]
(Fig. 1A,B). The mutant receptors a1L263Cb2c2 form an open
channel that could not be activated by GABA. This leucine
residue is conserved in all known subunits of acetylcholine, glycine
and GABAA receptors. It has been postulated that this residue
plays a role in the gating mechanism of the channel, where the
closure is achieved when the large hydrophobic leucine residues
move into the channel inhibiting ion flux (for review see [31]).
Most of the mutations studied here had little effect on the apparent
affinity to GABA. Mutations in residues a1V256 and a1T261 each
caused an approximately 30–20 fold decrease in the apparent
affinity of PCCP2 to inhibit currents induced by GABA. This may
suggest that PCCP2 directly interacts with these residues, but it
Figure 10. Effect of MTSET+ on the PCCP2 and picrotoxin inhibition of wild type and mutants GABAA receptors. Currents were elicited
with GABA EC10. The concentration of PCCP
2 or picrotoxin was chosen such as to inhibit about 50% of the late current response in the corresponding
receptor. Subsequently oocytes were treated with the cysteine-reactive reagent MTSET+ and inhibition by the same concentration of PCCP2 or
picrotoxin was determined. The ratio of the inhibition after treatment divided by inhibition before treatment is shown as a bar. A, C, MTSET+ was
applied in the absence of GABA. B, D, MTSET+ was applied in the presence of 100 mM GABA. The circle symbol on top of the bar for the T260C and
T264C mutations indicates formation of an open channel after MTSET+ treatment when applied in the presence of GABA. The white bars show results
of experiments where the MTSET+ + GABA treatment was performed in the presence of 1 mM PCCP2 or 1 mM picrotoxin, in order to see if the
covalent reaction could be prevented by the channel blockers. The asterisks sign (*) indicates that 1 mM picrotoxin was not able to suppress
formation of open channels. Mean 6 SD is shown. The number of oocytes for each experimental condition is either three or six.
doi:10.1371/journal.pone.0106688.g010
Figure 11. Hypothetical model for the mechanism of action of
PCCP2. Mutation of residues a1V256 and a1T261 to cysteine alters
strongly the apparent affinity for channel inhibition by PCCP2. The fact
that MTSET+ can only react with cysteines introduced in M2 in the
presence of GABA indicates that GABA widens the pore. For the
mutations a1V256C and a1T260C the affinity for PCCP
2 is strongly
increased after MTSET+ treatment. MTSET+ reaction is prevented by
PCCP2. This together implies these residues in PCCP2 binding.
Introduction of two positive charges by reaction with MTSET+ further
up in the channel leads to additional binding sites for PCCP2.
doi:10.1371/journal.pone.0106688.g011
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cannot be excluded here that these two residues allosterically affect
the PCCP2 binding site. The mutations did not affect the
apparent affinity for picrotoxin to inhibit current elicited by
GABA.
It was of interest to test accessibility of the introduced cysteines
to a cysteine reactive reagent. MTSET+ was chosen as it had a
negligible effect on wild type receptors. It should be noted that a
receptor pentamer has two a1 subunits and that covalent reaction
of a mutated receptor with MTSET+ introduces two positive
charges. Evidence was obtained that MTSET+ has better access to
the channel lumen in the presence of the channel agonist GABA
and can penetrate as far as a1V256. Similar observations have
been made by Xu et al. [32] using a different cysteine reactive
reagent.
Interestingly, covalent reaction of MTSET+ with a1V256Cb2c2,
a1T260Cb2c2, a1L263Cb2c2, a1T264Cb2c2 and a1T267Cb2c2,
led to an increase in the apparent affinity for PCCP2 for channel
inhibition. The fact that introduction of a relatively bulky moiety
leads to an increase in affinity is probably due introduction of
positive charges that favorably interact with the negatively charged
PCCP2. Covalent reaction of MTSET+ with a1V256Cb2c2,
a1T260Cb2c2 and a1T267Cb2c2 was prevented in the presence of
PCCP2. The simplest interpretation of our observations including
the direct effect of the mutations a1V256C and a1T261C on the
affinity of PCCP2 is that PCCP2 can penetrate almost down to
the level of a1V256C. Binding of PCCP
2 then prevents MTSET+
access by channel constriction (Figure 11). However, we cannot
exclude that PCCP2 has a second binding site at the level of
a1T267 that is not sensitive to the mutation of this residue to
cysteine.
Hydrophobic anions have previously been described to inhibit
GABAA receptors in a voltage independent fashion [33] reportedly
in the absence of a conventional ligand binding site. Similar to the
observations made here the mutation of residue a1V256 located in
M2 affected inhibition. We can not fully exclude the possibility of
an action of PCCP2 outside the channel, but following
observations are in line with the existence of a binding site for
PCCP2 within the channel: a) off currents upon removal of
PCCP2, b) site of action in the inner leaflet of the membrane
(coinciding with the location of a1V256/a1T260/a1T261,
c) increase in the affinity for PCCP2 after introduction of positive
charges in the form of MTSEA+ into M2 and d) prevention by
PCCP2 of the reaction of MTSEA+ in different positions.
PCCP2 is a rigid symmetric molecule with a diameter of
approximately 10 A˚ that can engage in interactions with metals
and form hydrogen bonds with its five peripheral nitrogen atoms.
These bonds can extend along the C,N-axis or at a slightly bent
angle (Fig. 1B). We think that the most likely interpretation of our
findings is that PCCP2 blocks the receptor by plugging the pore at
the level of a1V256C, a1T260 and a1T261, adopting a position
parallel to the lipid bilayer. Figure 12A,B depicts a molecular
model of the binding site of PCCP2. The ligand is in a planar
position between the highly conserved 69 level threonines (a1T260)
forming H-bonds with the hydroxy groups, and the variable 29
level of a1V256 and the homologous b2A251 and c2T267. These
protein-ligand contacts are consistent with the observed affinity
differences for different pentamers, as the shape complementarity
and surface properties of the 29 level will be unique for each homo-
or hetero-pentameric receptor. The relatively slow rate of block
could be due to the strong tendency of PCCP2 to form H-bridges.
It may be hypothesized that on the way down the channel lumen it
interacts several times with the receptor.
It is interesting to compare the binding site for PCCP2 to that of
picrotoxin, a well-known open channel blocker. Considerably
controversy exists if picrotoxin occludes the channel directly or
whether it allosterically affects the channel (reviewed in [34] and
references therein). Possibly the best evidence for channel
occupancy comes from crystallization experiments. The crystal
structure of the homo-pentameric Caenorhabditis elegans gluta-
mate-gated chloride channel a (GluCl) shows that picrotoxin (9 A˚
diameter) directly occludes the pore near its cytosolic base at the 29
Thr and -29 Pro side chains [35]. In this position, the channel
diameter in static condition of the crystal is 4.6 A˚. These residues
are homologous to P252 and V256 in the M2 of the a1 GABAA
receptor subunit. Thus, it appears that PCCP2 and picrotoxin
occupy sites in the lumen of the channel toward the intracellular
side of the transmembrane domain that are shifted by one turn of
the a-helix.
Pentasymmetric protein assemblies are not confined to Cys-loop
receptors but frequently occur elsewhere in Nature, for instance in
mechanosensitive ion channels, such as MscL, or bacterial toxins,
such as Shiga toxin B. Indeed, symmetry-adapted inhibitors for the
latter have been developed that show extremely high avidity
(picomolar) due to their polyvalency [36]. More recently,
polycationic blockers of voltage gated potassium channels based
on a four-fold symmetric calixarenes [36] and a blocker of
the heptameric Anthrax PA channel based on seven-fold
symmetric b-cyclodextrin [37] have been introduced. This
underscores that symmetry considerations hold considerable
promise for the development of new pharmacophores. Given the
prevalence of symmetric protein assemblies in Nature, it seems
likely that many symmetry adapted agonists, antagonists and
blockers will emerge in future years.
In conclusion, we have identified a new potent blocker of
GABAA receptors through rational design rather than a massive
screening effort. Our work demonstrates that symmetry consider-
ations can contribute to the pharmacology of Cys-loop receptors.
Figure 12. Molecular model of the interaction of PCCP2 with
GABAA receptors. A, The side view of the PCCP
2 docking pose from
the perspective of the c2 subunit. The ligand and the mutated residues
of the a1 subunit, which have an impact on the affinity of the ligand, are
shown in space filling representation. The 29 valines of the a1 subunit
are rendered grey; the 69 threonines of the a1 subunit in green. The
GABAA receptor is displayed in ribbon representation with a1 subunits
shown in yellow, b2 subunits in red, c2 subunit in blue. The complete
transmembrane domain (TMD) is shown only of the a1 and the b2
subunits in the back. Of the subunits in front, only a segment of the
transmembrane domain 2 (TMD2) is depicted. The TMD2 of the c2
subunit is only partly displayed to provide a ‘‘window’’ through which
the ligand is seen. B, Top view of the pose showing the symmetric
molecular interactions between ligand and receptor. PCCP2 (space
filling) forms H-bonds (blue dashed lines) to the –OH groups of the 69
threonines (stick representation) of each of the five subunits.
doi:10.1371/journal.pone.0106688.g012
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The application of other five-fold-symmetric molecular platforms
including some shown in Fig. 1 to the development of high-affinity
ligands for GABAA receptors as well as other five-fold symmetric
ion channels such as mechanosensitive channels is under active
investigation and will be reported in due course.
Acknowledgments
We thank V. Niggli for careful reading of the manuscript and M.E.
Steinmann and S.J. Middendorp for frog surgery. We are grateful for the
generous gift of cDNA coding for subunits of the Drosophila GABAA
receptor that were obtained from Dr. D. Sattelle, glycine receptor from Dr.
B. Laube and Dr. H. Betz and ELIC from Dr. R. Dutzler.
Author Contributions
Conceived and designed the experiments: DT ES. Performed the
experiments: VC MP RB. Analyzed the data: VC DT ES. Contributed
reagents/materials/analysis tools: RP ME. Contributed to the writing of
the manuscript: VC DT ES.
References
1. Hargittai I, Hargittai M (1994) Symmetry, a unifying concept. Random House.
2. Prasad BVV, Schmid MF (2012) Principles of virus structural organization, in
Viral Molecular Machines, Advances in Experimental Medicine and Biology
726 Rossmann MG, Rao VB (eds.), Springer.
3. Macdonald RL, Olsen RW (1994) GABAA receptor channels. Annu Rev
Neurosci 17: 569–602.
4. Sieghart W (1995) Structure and pharmacology of gamma-aminobutyric acid A
receptor subtypes. Pharmacol Rev 47: 181–234.
5. Sieghart W, Sperk G (2002) Subunit composition, distribution and function of
GABA(A) receptor subtypes. Curr Top Med Chem 2: 795–816.
6. Sigel E, Steinmann ME (2012) Structure, function, and modulation of GABAA
receptors. J Biol Chem 287: 40224–31.
7. Olsen RW, Sieghart W (2008) International Union of Pharmacology. LXX.
Subtypes of gamma-aminobutyric acid (A) receptors: classification on the basis of
subunit composition, pharmacology, and function. Update. Pharmacol Rev 60:
243–60.
8. Chang Y, Wang R, Barot S, Weiss DS (1996) Stoichiometry of a recombinant
GABAA receptor. J Neurosci 16: 5415–5424.
9. Tretter V, Ehya N, Fuchs K, Sieghart W (1997) Stoichiometry and assembly of a
recombinant GABAA receptor subtype. J Neurosci 17: 2728–2737.
10. Baumann SW, Baur R, Sigel E (2001) Subunit arrangement of gamma-
aminobutyric acid type A receptors. J Biol Chem 276: 36275–36280.
11. Baumann SW, Baur R, Sigel E (2002) Forced subunit assembly in a1b2c2
GABAA receptors. Insight into the absolute arrangement. J Biol Chem 277:
46020–46025.
12. Baur R, Minier F, Sigel E (2006) A GABAA receptor of defined subunit
composition and positioning: concatenation of five subunits. FEBS Lett 580:
1616–1620.
13. Sigel E, Baur R, Trube G, Mohler H, Malherbe P (1990) The effect of subunit
combination of rat brain GABAA receptors on channel function. Neuron 5: 703–
711.
14. Minier F, Sigel E (2004) Positioning of the a-subunit isoforms confers a
functional signature to c-aminobutyric acid type A receptors. Proc Natl Acad Sci
USA 101: 7769–7774.
15. Raymond-Delpech V, Matsuda K, Sattelle BM, Rauh JJ, Sattelle DB (2005) Ion
channels: molecular targets of neuroactive insecticides. Invert Neurosci 5: 119–
133.
16. Martos V, Bell SC, Santos E, Isacoff EY, Trauner D, et al. (2009) Calix[4]arene-
Based Conical-Shaped Ligands for Voltage Dependent Potassium Channels.
Proc Natl Acad Sci USA 106: 10482–10486.
17. Mammen M, Choi S-K, Whitesides GM (1998) Polyvalent interactions in
biological systems: Implications for design and use of ligands and inhibitors,
Angew Chem Int Ed 37: 2754–2794.
18. Sigel E (1987) Properties of single sodium channels translated by Xenopus
oocytes after injection with messenger ribonucleic acid. J Physiol 386: 73–90.
19. Sali A, Blundell TL (1993) Comparative protein modelling by satisfaction of
spatial restraints. J Mol Biol 234: 779–815.
20. Cole JC, Nissink JWM, Taylor R (2005) Protein-ligand docking and virtual
screening with GOLD in Virtual Screening in Drug Discovery (Eds. Shoichet B,
Alvarez J) Taylor & Francis CRC Press, Boca Raton, Florida, USA.
21. Simmons HE, Vest RD, Vladuchick SA, Webster OW (1980) Thiacyanocar-
bons. 5. Reactions of tetracyano-1,4-dithiin and tetracyanothiophene with
nucleophiles: Synthesis of tetracyanopyrrole and tetracyanocyclopentadiene
salts. J Org Chem 45: 5113–5121.
22. Less RJ, McPartlin M, Rawson JM, Wood PT, Wright DS (2010) A simple
approach to coordination compounds of the pentacyanocyclopentadienide
anion. Chem Eur J.16: 13723–13728.
23. Goff EL, LaCount RB (1964) Condensation of dimethyl acetylenedicarboxylate
with malonnitrile, ethyl cyanoacetate and malonate esters. J Org Chem 29: 423–
427.
24. Betz H, Laube B (2006) Glycine receptors: recent insights into their structural
organization and functional diversity. J Neurochem 97: 1600–1610.
25. Hilf RJ, Dutzler R (2008) X-ray structure of a prokaryotic pentameric ligand-
gated ion channel. Nature 452: 375–379.
26. Woodhull AM (1973) Ionic blockage of sodium channels in nerve. J Gen Physiol
61: 687–708.
27. ffrench-Constant RH, Rocheleau TA, Steichen JC, Chalmers AE (1993) A point
mutation in a drosophila GABA receptor confers insecticide resistance. Nature
363: 449–451.
28. ffrench-Constant RH, Steichen JC, Rocheleau TA, Aronstein K, Roush RT
(1993) A single-amino acid substitution in c-aminobutyric acid subtype A
receptor locus is associated with cyclodiene insecticide resistence in Drosophila
populations. Proc Natl Acad Sci USA 90: 1957–1961.
29. Xu M, Akabas MH (1996) Identification of channel-lining residues in the M2
membrane-spanning segment of the GABAA receptor alpha1 subunit. J Gen
Physiol 107: 195–205.
30. Perret P, Sarda X, Wolff M, Wu TT, Bushey D, et al. (1999) Interaction of non-
competitive blockers within the gamma-aminobutyric acid type A chloride
channel using chemically reactive probes as chemical sensor for cysteine
mutants. J Biol Chem 274: 25350–25354.
31. Unwin N (1989) The structure of ion channels in membranes of excitable cells.
Neuron 3: 665–676.
32. Xu M, Covey DF, Akabas MH (1996) Interaction of picrotoxin with GABAA
receptor channel-lining residues probed in cysteine mutants. Biophys. J. 69:
1858–1867.
33. Chisari M, Wu K, Zorumski CF, Mennerick S (2011) Hydrophobic anions
potently and uncompetitively antagonize GABA(A) receptor function in the
absence of a conventional binding site. Br J Pharmacol 164: 667–680.
34. Korshoej AR, Holm MM, Jensen K, Lambert JDC (2010) Kinetic analysis of
evoked IPSCs discloses mechanism of antagonism of synaptic GABAA receptors
by picrotoxin. Brit J Pharmacol 159: 636–649.
35. Hibbs RE, Gouaux E (2011) Principles of activation and permeation in an
anion-selective Cys-loop receptor. Nature, 474: 54–60.
36. Martos V, Castreno P, Valero J, de Mendoza J (2006) Binding to protein
surfaces by supramolecular multivalent scaffolds. Curr Opin Chem Biol 12: 698–
706.
37. Karginov VA, Yohannes A, Robinson TM, Fahmi NE, Alibek K, et al. (2005)
b-Cyclodextrin derivatives that inhibit anthrax lethal toxin. Bioorg Med Chem
14: 33–40.
An Open Channel Blocker for Cys-Loop Receptors
PLOS ONE | www.plosone.org 10 September 2014 | Volume 9 | Issue 9 | e106688
